Elexacaftor-tezacaftor-ivacaftor decreases pseudomonas abundance in the sinonasal microbiome in cystic fibrosis.
Anna C ZemkeYasmin HilliamAmanda L StapletonAdam J KimpleJennifer L GoralskiAmber D ShafferJoseph M PilewskiBrent A SeniorStella E LeeVaughn S CooperPublished in: International forum of allergy & rhinology (2023)
Treatment with ETI leads to a reduction in Pseudomonas abundance within the sinonasal microbiome of individuals with Pseudomonas at baseline.